MedPath

Hydralazine Hydrochloride

Hydralazine Hydrochloride Injection, USP Preservative Free Rx only

Approved
Approval ID

f0db9c3c-d841-46f9-8409-9ffca83d7a97

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 27, 2025

Manufacturers
FDA

Zydus Pharmaceuticals USA Inc.

DUNS: 156861945

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Hydralazine Hydrochloride

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code70710-1988
Application NumberANDA202938
Product Classification
M
Marketing Category
C73584
G
Generic Name
Hydralazine Hydrochloride
Product Specifications
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS
Effective DateMarch 27, 2025
FDA Product Classification

INGREDIENTS (5)

HYDRALAZINE HYDROCHLORIDEActive
Quantity: 20 mg in 1 mL
Code: FD171B778Y
Classification: ACTIB
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32I
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hydralazine Hydrochloride - FDA Drug Approval Details